Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt Bioscience

Premium

Agencourt Bioscience has launched an expanded SNP-discovery service for pre-validated sequencing assays of kinases.

The company has also said it has licensed the new service to the Dana-Farber Cancer Institute, which will use it to sequence assays developed by cancer researchers Matthew Meyerson, and William Sellers. For this deal, Agencourt will offer both pre-validated sequencing assays and a kinase-discovery program in which polymorphisms in more than 92 kinases have previously been mapped. Financial terms of the licensing agreement were not released.

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.